Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Current Assets (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Current Assets for 16 consecutive years, with $11.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Current Assets fell 6.34% to $11.8 million in Q4 2025 year-over-year; TTM through Nov 2025 was $11.8 million, a 6.34% decrease, with the full-year FY2025 number at $11.8 million, down 6.34% from a year prior.
  • Current Assets was $11.8 million for Q4 2025 at Cryo Cell International, up from $11.7 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $18.7 million in Q1 2021 to a low of $9.5 million in Q1 2024.
  • A 5-year average of $11.9 million and a median of $10.9 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: crashed 48.03% in 2022, then skyrocketed 32.81% in 2024.
  • Cryo Cell International's Current Assets stood at $15.8 million in 2021, then plummeted by 39.11% to $9.6 million in 2022, then dropped by 1.64% to $9.5 million in 2023, then surged by 32.81% to $12.6 million in 2024, then fell by 6.34% to $11.8 million in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Current Assets are $11.8 million (Q4 2025), $11.7 million (Q3 2025), and $13.1 million (Q2 2025).